Anti-HRSV Fusion Protein Reference Antibody (Felvizumab, RUO)

SKU: VK421046

Size:100ug

Description:Felvizumab [HuRSV19VHFNS/VK, RSHZ19, RSV monoclonal antibody, SB209763] is a humanised monoclonal antibody (IgG1) prepared by the humanization of an F protein-specific murine MAb. In in vitro studies, palivizumab, another humanized Mab specific for the F protein of RSV, was 4 to 5-fold more potent than felvizumab in neutralising RSV (Scott, 1999).

Host species:Humanized

Tested applications:

Species reactivity:HRSV-A

Form:Liquid

Storage buffer:0.01M PBS, pH 7.4.

Purity:>95% purity as determined by SDS-PAGE.

Clonality:Monoclonal

Isotype:IgG1, kappa

Applications:ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Target:F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1

Purification:Protein A/G purified from cell culture supernatant.

Endotoxin level:Please contact us for this information.

Expression system:Mammalian Cells

Accession:P03420

Stability and Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

Reconstitution:

Background:

Alternative Names:SB209763, HuRSV19VHFNS/VK, RSHZ19monoclonalantibody, SB209763, 167747-20-8

Clone ID:

Species:

Note:For research use only. Not suitable for clinical or therapeutic use.